IT8748116A0 - Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche - Google Patents

Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche

Info

Publication number
IT8748116A0
IT8748116A0 IT8748116A IT4811687A IT8748116A0 IT 8748116 A0 IT8748116 A0 IT 8748116A0 IT 8748116 A IT8748116 A IT 8748116A IT 4811687 A IT4811687 A IT 4811687A IT 8748116 A0 IT8748116 A0 IT 8748116A0
Authority
IT
Italy
Prior art keywords
preventive
therapeutic agents
diabetic complications
glycine derivatives
glycine
Prior art date
Application number
IT8748116A
Other languages
English (en)
Other versions
IT1206822B (it
Inventor
Murase Masao
Maruo Shigeaki
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of IT8748116A0 publication Critical patent/IT8748116A0/it
Application granted granted Critical
Publication of IT1206822B publication Critical patent/IT1206822B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT8748116A 1986-06-27 1987-06-26 Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche IT1206822B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15214986 1986-06-27

Publications (2)

Publication Number Publication Date
IT8748116A0 true IT8748116A0 (it) 1987-06-26
IT1206822B IT1206822B (it) 1989-05-03

Family

ID=15534103

Family Applications (2)

Application Number Title Priority Date Filing Date
IT8748116A IT1206822B (it) 1986-06-27 1987-06-26 Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche
IT8748117A IT1206823B (it) 1986-06-27 1987-06-26 Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche

Family Applications After (1)

Application Number Title Priority Date Filing Date
IT8748117A IT1206823B (it) 1986-06-27 1987-06-26 Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche

Country Status (6)

Country Link
US (2) US4785018A (it)
JP (2) JPS6399057A (it)
DE (2) DE3721223A1 (it)
FR (2) FR2600646B1 (it)
GB (2) GB2192002B (it)
IT (2) IT1206822B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196849B (it) * 1986-02-16 1988-11-25 Rotta Research Lab Nuovi derivati degli acidi 5 pentilammino 5 oxo pentaoico e 4 pentilammino 4 oxo butanoico ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
CA1307537C (en) * 1987-12-23 1992-09-15 Jay E. Wrobel N-naphthoylglycines as aldose reductase inhibitors
US4962224A (en) * 1987-12-23 1990-10-09 American Home Products Corporation N-naphthoylglycines as aldose reductase inhibitors
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
DE69634416T2 (de) * 1995-11-24 2005-12-29 Glaxosmithkline S.P.A. Chinolin-derivate
ES2222576T3 (es) * 1997-03-14 2005-02-01 Smithkline Beecham Corporation Nueva quinolina- y naftalenocarboxamidas, composiciones farmaceuticas y procedimientos que inhiben el calpain.
WO2002098421A1 (en) * 2001-06-05 2002-12-12 University Of Maryland, Baltimore Novel treatment for neurological and psychiatric disorders
WO2006034512A2 (en) * 2004-09-23 2006-03-30 Bayer Pharmaceuticals Corporation Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928610A (en) * 1970-06-06 1975-12-23 Hoechst Ag Benzene sulfonyl-urea preparation for treatment of diabetes mellitus and a method for treatment
US3939269A (en) * 1971-04-26 1976-02-17 Hoechst Aktiengesellschaft Benzenesulfon YL-semicarbazides for lowering blood sugar levels
JPS5216367A (en) * 1975-07-21 1977-02-07 Rikagaku Kenkyusho Plant growth control agent
US4195984A (en) * 1979-03-12 1980-04-01 Abbott Laboratories Herbicides derived from dihalo isonicotinoyl derivatives of amino acids
CA1176269A (en) * 1981-03-02 1984-10-16 Kazimir Sestanj N-naphthoylglycine derivatives
CA1182472A (en) * 1981-03-02 1985-02-12 Kazimir Sestanj N-[(2-naphthalenyl)thioxomethyl]glycine derivatives
AU544067B2 (en) * 1981-03-02 1985-05-16 Wyeth-Ayerst Canada Inc. Thioamides and amides. treatment of diabetes
US4337265A (en) * 1981-08-21 1982-06-29 Ayerst, Mckenna & Harrison Inc. Cyclohepta[b]pyrrole derivatives
US4604406A (en) * 1984-11-16 1986-08-05 Ayerst, Mckenna & Harrison, Inc. N-[6-methoxy-5-(perfluoroalkyl)-1-naphtholyl]-N-methylglycines and their thionaphthoyl analogs

Also Published As

Publication number Publication date
DE3721223C2 (it) 1991-11-14
US4970214A (en) 1990-11-13
IT1206822B (it) 1989-05-03
IT8748117A0 (it) 1987-06-26
DE3721223A1 (de) 1988-01-14
FR2600647B1 (fr) 1991-10-18
FR2600646A1 (fr) 1987-12-31
US4785018A (en) 1988-11-15
DE3721222A1 (de) 1988-01-14
JPS6399057A (ja) 1988-04-30
GB8715055D0 (en) 1987-08-05
JPS63119455A (ja) 1988-05-24
GB2192002A (en) 1987-12-31
IT1206823B (it) 1989-05-03
FR2600646B1 (fr) 1990-01-26
FR2600647A1 (fr) 1987-12-31
GB2193210B (en) 1990-03-28
GB8715056D0 (en) 1987-08-05
GB2193210A (en) 1988-02-03
GB2192002B (en) 1990-04-11

Similar Documents

Publication Publication Date Title
DE3781263D1 (de) Peptid-derivate und deren verwendung in der therapie.
EP0242328A3 (en) Pharmaceutical composition for treating inflammation in the eye
TR23322A (tr) Alfa-aril-alfa-feniletil-1h-1,2,4-triazol-1-propannitriller
DK90089D0 (da) Hudbehandlingspraeparat
DK295190A (da) Kosmetik- og hudbehandlingssammensaetninger
PT87554A (pt) Didinfecting and sterilizing composition
IT1206822B (it) Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche
DE3876075D1 (de) Uv-haertbare und in schattengebieten mit feuchtigkeit haertbare zusammensetzungen.
EP0437026A3 (en) Use of tandospirone in the treatment of depression
GB2201171B (en) Compositions for use in the treatment of cellulosic materials and their preparation
AU3752189A (en) Pharmaceutical compositions and use thereof in treating inflammation
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
GB2222022B (en) Improvements in and relating to semiconductor lasers
GB2226494B (en) Photosynthesis in men's blood to cure cancer-part 2 phmd(cancer)
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
AU3039789A (en) Active substance for treating changes in the skin and mucous membranes
GB2213373B (en) Po-man's photosynthesis in men's blood to cure cancer (phmdcc)
BR8902395A (pt) Composicao curavel e artigo
ATE79636T1 (de) Peptid-derivate und deren verwendung in der therapie.
NO933877D0 (no) Fremgangsmaate for aa forhindre blokkering i katetere
LV5819A4 (lv) (-)-benzhidrilsulfinilacetamids ta iegusanas panemiens un ta izmantosana terapija
RO105585B1 (ro) Compozitie medicamentoasa folosita in tratamentul ulcerului de gamba
IT8819742A0 (it) Procedimento per il riempimento e/o l'otturazione in interventi chirurgici e odontoiatrici.
LT2576B (lt) Cholesterino nustatymo kraujyje budas
RO93626A2 (ro) Material de amprentare termoplastic utilizat in stomatologie

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19930419